Simulations Plus, Inc.

Modeling & simulation software and consulting for pharma/biotech to accelerate drug development.

SLP | NDAQ

Overview

Corporate Details

ISIN(s):: US8292141053
LEI:
Country:: United States of America
Address:: 800 PARK OFFICES DRIVE, SUITE 401, 27709 RESEARCH TRIANGLE PARK
Website:: https://www.simulations-plus.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Simulations Plus, Inc. is a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and other science-based industries. The company specializes in solutions that support drug discovery and development, from early research and clinical development to regulatory submissions. Its flagship products, including GastroPlus® and ADMET Predictor®, utilize advanced technologies like AI/machine learning, physiologically based pharmacokinetic (PBPK), quantitative systems pharmacology (QSP), and quantitative systems toxicology (QST) modeling. These tools enable scientists to predict the properties and effects of chemical and biological compounds, helping to optimize drug design, predict safety and efficacy, and accelerate the development timeline. The company serves a global client base, including major pharmaceutical companies, regulatory agencies, and academic institutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Simulations Plus, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Simulations Plus, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Simulations Plus, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
DIGITAL HOLDINGS,INC. Drives business DX with data-driven advertising, CRM consulting, and AI integration.	Japan	2389
DIGITALIFT Inc. Digital marketing firm providing programmatic ad operations and strategic consulting services.	Japan	9244
D.L.S.I. HR and recruitment services for temp, fixed-term, and permanent roles across industries.	France	ALDLS
Dogwood Therapeutics, Inc. Developing non-opioid therapeutics for neuropathic pain, fibromyalgia, and cancer-related pain.	United States of America	DWTX
Doric Nimrod Air Three Limited Investment firm leasing four Airbus A380s to Emirates for shareholder returns.	Guernsey	DNA3
DP Aircraft I Limited Acquires, leases, and sells Boeing 787-8 aircraft to commercial airlines for investors.	Guernsey	DPA
DreamCIS INC. A CRO providing clinical research services for pharma, biotech, and medical device industries.	South Korea	223250
DT&CRO CO., Ltd. A full-service CRO for pharma & biotech, from non-clinical studies to FDA approval support.	South Korea	383930
DUSKIN CO.,LTD. Franchises cleaning rentals and services for homes and businesses, and operates food chains.	Japan	4665
D.Western Therapeutics Institute, Inc. Biotech firm discovering and licensing drug candidates, focusing on kinase inhibitors.	Japan	4576